文献速递创伤骨科关节外科

诺丁汉髋部骨折评分:超越髋部骨折的应用

The Nottingham Hip Fracture Score : beyond the hip.
PubMed 文献 · Bone Joint J · 2025-11-01

该研究回顾了2015年12月至2022年6月英国一家主要创伤中心连续收治的431例老年股骨骨折患者,其中假体周围骨折211例、原生股骨骨折220例,评估诺丁汉髋部骨折评分(NHFS)对30天和一年死亡率的区分能力。结果显示30天死亡率为7.4%、一年死亡率为25.1%,NHFS对30天死亡率(AUROC 0.746(95%CI 0.666至0.826))、一年死亡率(AUROC 0.777(95%CI 0.730至0.825))及整个研究期间(AUROC 0.733(95%CI 0.686至0.780))均有区分能力,所有p<0.001。作者主张将该评分用于预后判断、改善患者咨询和指导围手术期管理。

要点

  • NHFS在431例老年股骨骨折患者中可计算于427例(99%),中位NHFS为5(IQR 4至6)。
  • 30天死亡率为7.4%,一年死亡率为25.1%。
  • NHFS各亚组间生存曲线在所有时间点均有显著差异(p≤0.001)。

核心结论

  • NHFS能在所有时间点区分生存情况,其准确性与髋部骨折队列中的验证研究相似。
  • 作者主张使用NHFS帮助预后判断、改善患者咨询并指导该困难患者群体的围手术期管理。
  • 作者希望采用统一的脆性股骨骨折风险分层工具可能改善假体周围、骨干和股骨远端骨折相对于髋部骨折在治疗上的差异。

研究设计与样本

  • 回顾了2015年12月至2022年6月英国一家主要创伤中心连续收治的患者。
  • 纳入标准为年龄>65岁、AO股骨骨折32或33型、或假体周围股骨骨折B至E型(统一分类系统)。
  • 排除开放性骨折和多发伤患者。
  • 共纳入431例患者,包括假体周围骨折211例和原生股骨骨折220例。
  • 主要结局为NHFS对30天死亡率的风险分层能力,一年死亡率风险分层和出院非居家状态分别为次要和第三结局。

主要发现

  • NHFS可在427例(99%)患者中计算,中位NHFS为5(IQR 4至6)。
  • 30天死亡率为7.4%,一年死亡率为25.1%。
  • NHFS各亚组间生存曲线在所有时间点均有显著差异(p≤0.001)。
  • NHFS对30天死亡率的AUROC为0.746(95%CI 0.666至0.826)。
  • NHFS对一年死亡率的AUROC为0.777(95%CI 0.730至0.825),对整个研究期间的AUROC为0.733(95%CI 0.686至0.780),所有p<0.001。

临床怎么用

  • 作者主张使用NHFS帮助预后判断、改善患者咨询并指导该困难患者群体的围手术期管理。
  • 作者希望采用统一的脆性股骨骨折风险分层工具可能改善假体周围、骨干和股骨远端骨折相对于髋部骨折在治疗上的差异。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

AIMS: The Nottingham Hip Fracture Score (NHFS) is an established risk-stratification tool for 30-day mortality in patients sustaining femoral neck fractures. Despite increasing awareness of the morbidity of femoral fractures in the physiologically frail patient, and of the similarities between hip fractures and those sustaining periprosthetic, diaphyseal, and distal femoral fractures, there is a paucity of research exploring whether the NHFS could be used to prognosticate mortality in this wider cohort. METHODS: We reviewed a consecutive series of patients presenting to a UK major trauma centre between December 2015 and June 2022. Inclusion criteria were patients aged > 65 years with AO femoral fracture 32 or 33, or periprosthetic femoral fractures type B to E (Unified Classification System). Open fractures and polytraumatized patients were excluded. Primary outcome was the ability of the NHFS to risk-stratify mortality at 30 days, with risk stratification of mortality at one year and non-homebound discharge as secondary and tertiary outcomes, respectively. RESULTS: A total of 431 patients were included, comprising 211 periprosthetic and 220 native femoral fractures. NHFS was calculable in 427 patients (99%) with median NHFS 5 (IQR 4 to 6). The 30-day and one-year mortality was 7.4% and 25.1%, respectively. Survival curves diverged significantly between NHFS subgroups at all timepoints (p ≤ 0.001). Considering the area under the receiver operating characteristic (ROC) curves (AUROC), NHFS discriminated mortality at 30 days (AUROC 0.746 (95% CI 0.666 to 0.826)), one year (AUROC 0.777 (95% CI 0.730 to 0.825)), and throughout the study period (AUROC 0.733 (95% CI 0.686 to 0.780)), all at p < 0.001. CONCLUSION: NHFS was able to discriminate survival at all timepoints with similar accuracy to the validating studies in the hip fracture cohort. We advocate its use to help prognosticate, improve patient counselling, and direct perioperative care for this challenging group of patients. We hope that adopting a unified risk-stratification tool for fragility femoral fractures might improve the disparity with which periprosthetic, diaphyseal, and distal femoral fractures are treated with regard to hip fractures.

来源:Bone Joint J,查看原文。版权归原作者所有。

引用

  1. Borton Z, Firth AM, Arnold SJ, et al. The Nottingham Hip Fracture Score : beyond the hip. Bone Joint J. 2025. PMID: 41173030. doi:10.1302/0301-620X.107B11.BJJ-2024-1635.R2

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。